Toxicological Research

  • 제11권2호
  • /
  • Pages.253-259
  • /
  • 1995
  • /
  • 1976-8257(pISSN)
  • /
  • 2234-2753(eISSN)
한국독성학회 (Korean Society of Toxicology & Korea Environmental Mutagen Society)
권호 표지

흰쥐에 있어서 주정중독이 Bromobenzene 대사에 미치는 영향

Effect of Ethanol Pretreatment on the Bromobenzene Metabolism in Rats

  • 김중우 (경산대학교 보건대학원 보건학과) ;
  • 신중규 (경산대학교 보건대학원 보건학과) ;
  • 윤종국 (계명대학교 자연과학대학 공중보건학과)
  • 발행 : 1995.12.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

To investigate an effect of ethanol pretreatment on the bromobenzene metabolism, the brornobenzene (400 mg/kg body wt. i. p.) was given 3 times at intervals of one day to the male rats orally pretreated with 5% ethanol throughout 2 months. In the ethanol pretreated rats, liver injuries were not demonstrated on the basis of the liver weight per body weight, serum levels of alanine aminotransferase (ALT) activity and histopathologic findings. By the bromobenzene treatment, ethanol pretreated rats showed the more decreased levels of serum ALT and liver weight/body weight(%), and decreased degree of liver damage on histopathological observation than the control group. The ethanol pretreated rats showed the more increased activities of hepatic aniline hydroxylase, glutathione Stransf erase (GST) and the more decreased contents of glutathione than the control. Concomitantly the ethanol pretreated rats showed the more decreased contents of hepatic glutathione and increased activities of GST by the bromobenzene treatment. Above results indicate that ethanol pretreatment enhance the metabolizing ability of bromobenzene in rats.

키워드

참고문헌

  1. N. Eng1. J. Med. v.280 Hepatic bilirubin UDP-glucuronyl transferase activity in liver disease; Gilbert's syndrome Black,M.;Billing,B.H.
  2. N. Eng1. J. Med. v.280 The role of glucuronyl transferase activity in liver disease; Gilbert's syndrome Boyland,E.;Billing,B.H.
  3. Microsomal oxidation of ethanol and the drug metabolizing system studies in animals and man. Metabolic changes Induced by Alocohol Carull,N.;Manenti,F.;ed.G.A.Martini;ed.Ch Bode
  4. Pathology of The Liver Alcoholic liver disease, in Macs-Ween RNM, Anthony pp. Christoflersen,P.;Poulsen,H.;ed.Scheuer,P.J.
  5. Biochem. Pharmacol. v.34 Activities of several phase I and Phase I xenobiotics biotransformation enxymes in cultured hepatocytes from male and female rats Croci,T.;Williams,G.M.
  6. Lab. Invest. v.47 Biology of disease: Free fadicals and tissue injury Freeman,B.A.;Crapo,J.D.
  7. Toxicol Appl. pharmacol. v.67 no.2 Effect of chronic ethanol administration in bromobenzene liver toxicity in the rat Hetu,C.;Dumont,A.;Joly,J.G.
  8. Modification on metabolism Modern Toxicology Hodgson,E.;ed.E.Hodgson;P.E.Levi
  9. Xenobiotica v.7 no.1-2 Drug metabolism under pathological and abnormal physiological states in animals and man Kato,R.
  10. Korean J. Pharmacol v.26 Protective effect of diallyl disulfide on the bromobenzene-induced hepatotoxicity in mice Lee,S.I.;Yoon,C.G.;Huk,K.
  11. J. Biol. Chem. v.193 Protein measurement with the folin pnenol reagent Lowry,O.H.;Rosebrought,N.J.;Farr,A.L.;Randall,R.J.
  12. J. Biol. Chem. v.244 Superoxide dismutase: An enzymatic function for erythrocuprein (hemocuprein) McCord,J.M.;Fridovich,I.
  13. Enzyme. v.24 no.3 Studies of human liver bilirubinglycosly transferase. Bilirubin UDP-xylosyl and UDP-glucronyl transferase activities in diseased human liver Motayama,Y.
  14. Korean J. Pharmacol. v.18 Effect of oxygen-derived free radicals on brain microsomal Na-K ATP ase activity Oh,S.M.;Son,Y.S.;Choi,K.S.;Lim,J.K.;Chung,M.H.
  15. Pharmacologist v.12 On the mechanism by which organic compounds product tissue lesions. I Hepatotoxicity of aromatic hydrocarbons and enhancement by phenobarbital Reid,W.D.;Cho,A.K.;Krishan,G.;Brodie,B.B.
  16. Pharmacol. v.6 Bromobenzene metabolism and hepatic necrosis Reid,W.D.;Lhristie,B.;Krishan,G.;Mitchell,J.R.;Moskowitz,J.;Brodie,B.B.
  17. Science v.162 Hepatic microsomal enzymes in man and rats: induction and inhibition by ethanol Rubin,E.;Lieber,C.S.
  18. Diseases of the Liver and Biliary System (ed. 7) Sherlock,P.S.
  19. Eur. J. Clin. Pharmacol. v.4 Determination of drug metabolizing enzymes in needle biopsis of human liver Schoene,B.;Fleischman,R.A.;Remmer,H.
  20. 효성카톨릭 대학원 박사학위 논문 Bromobenzene이 흰쥐의 간손상시 효소활성에 미치는 영향 신중규
  21. New Engl. J. Med. v.303 Normobaric toxicity of lung Susan,M.D.;Barry,L.F.
  22. Arch Biochem. Biophys. v.192 no.2 Metabolic activation and hepatotoxicity. Effect of cysteine. N-acetylcysteine and methionine on glutathione biosynthesis and bromobenzene toxicity in isolated rat hepatocytes Thor,H.;Moldeus,P.;Orrenius,S.
  23. Biochem. Pharmacol. v.31 Activation of pharmacological agents to radical intermediated: Implications for the role of free radicals in drug action and toxicity Trush,A.M.;Mimnaush,E.G.;Gram,T.E.
  24. Hepatic metabolism of drugs and toxin Hepatology Vessey,D.A.;ed.Zakim;T.D.Boyer
  25. Hepatic function and pharmacokinetics Hepatology Williams,R.L.;Benet,L.Z.;ed.D.Zakin;ed.T.D.Boyer
  26. Liver disease in alcoholl addicted patient Alcoholism and Health Wooddell,W.J.;ed.Davidson,S.V.
  27. Clin. Pharmacol. Ther. v.17 Pharmacokinetics and metabolism of digoxin-and β-methyl-digoxin-12 α-3H in patients with acute hepatitis Zilly,W.;Richter,E.;Rietbrock,N.
  28. Xenobiotica v.21 no.4 Premercapturic acid metabolism of bromobenzene derived via its2,3-and 3,4-oxide metabolites Zheng,J.;Hanzlik,R.P.